Sitemap
- Vitenskap
- Helse og Medisinske Nyheter
- Vitenskap og Medisin
- Dermatologi
- Atopisk Dermatitt
- Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results1
- Exploring the Unique Characteristics of Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
- Advancing the treatment: Meeting the challenge of uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
- Underneath the skin
- Prurigo Nodularis: Behandlingsvalg
- Atopisk Dermatitt
- Sjelden blodsykdom
- Diabetes
- Type 2 Diabetes: Behandling og Forskning
- Type 1 Diabetes: Artikler og Behandling
- 45 factors impacting blood glucose
- Guidelines in type 1 diabetes american diabetes association, EASD & ISPAD
- Type 1 diabetes and exercise benefits and barriers when exercising
- Introduksjon til diabetes og trening
- Hybridmøtet 26. oktober om guidelines og type 1 diabetes
- Time to Rethink T1D?
- Infographic: Impact of Type 1 Diabetes Diagnosis
- Detectability of Autoimmune Type 1 Diabetes
- Global Developments in Early Detection
of Autoimmune Type 1 Diabetes - The Complex Burden of Autoimmune Type 1 Diabetes
- Autoimmune Type 1 Diabetes
- Need to identify risk of developing autoimmune type 1 diabetes? Test for autoantibodies!
- Kardiologi
- Dyslipidemi
- 2024 ESC Guidelines for the management of chronic coronary syndromes
- 146 for Lipid Management After ACS
- Cardiovascular diseases (CVDs) are the leading cause of death globally1
- Approach for patients with coronary artery disease (CAD): focus on LDL-C control
- Approach for patients with peripheral artery disease (PAD) + T2DM: focus on LDL-C control
- Dyslipidemi
- Luftveiene
- Sjelden sykdom
- Vaksiner
- Transplantasjon
- Utdannelse
- Dermatologi
- Diabetes
- Kardiologi
- Luftveiene
- Astma
- Podcasts
- FeNO er en sterk prediktor for eksaserbasjoner 1-*2
- Bak klinisk utrykk i ulike organer: Type 2 inflammasjon
- Nesten 60 % av pasienter med alvorlig astma hadde minst 2 forhøyede biomarkører *1
- IL-4, IL-13 og IL-5 er viktige drivere av astmapatofysiologi*2-*6
- Velg en behandling som retter seg mot biologien bak biomarkørene*2-4
- Sammenhengen med eksaserbasjoner var mer enn fire ganger høyere for pasienter med høy feno og høy EOS 1
- Professor Amy Paller: Burden of atopic dermatitis in children and adolecents
- Test de viktigste type 2-biomarkørerfor riktig diagnose*6
- Har du overiskten?
- Type 2 Symposium, Oslo 2023
- Type 2 symposium, 2024
- Nesepolyper (CRSwNP)
- Chronic Obstructive Pulmonary Disease (COPD)
- Astma
- Neurologi
- Sjelden blodsykdom
- Sjelden sykdom
- Lær mer om fordelene ved NGS sekvensering
- Fabry Sykdom: Ressurser
- Monitoring Matters Series
- Monitoring Matters Series
- Brosjyre om Fabry sykdom
- Building Care webinar series
- Chronic Kidney Disease
- Cardiovascular management in patients with Fabry disease
- Enhancing quality and improving outcomes: patient-first approach in Fabry disease
- Pain and GI symptoms management
- Depression management
- ERT infusions management
- A Heart for Fabry - Podcast
- Gaucher Sykdom: Innsikt
- Vaksiner
- Artikler om Medisin
- Onkologi
- Ressurser
- Diabetes: Behandling og Oppfølging
- Neurologi
- Onkologi
- Hudkreft
- Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
- Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
- Myelomatose
- Hudkreft
- Sjelden sykdom
- Vaksiner
- Medisinske Artikler og Ressurser
- Dermatologi
- Produkter
- Arrangementer
- Diabetes
- Dermatologi
- Luftveiene
- Astma
- Blood esinophils, FeNO, and the modifiable risk of asthma attacks
- RespTalks - Treatable traits and risk prediction in asthma
- The Natural History of Lung Function in Asthma and COPD
- Leonard B. Bacharier, MD: Management of severe asthma in children
- Kan dupixent senke IgE?
- Biologic therapies for severe asthma: Real life experience & Patient selection
- Sanofi symposium at the Congress of the Nordic Association of Otolaryngology, Reykjavik, May 2023
- RespTalks - Mucus Plugging Biology and effects in the airways
- European Respiratory Society (ERS) congress 2024
- Nesepolyper (CRSWNP)
- Astma
- Artikler og Arrangementer
- Kontakt
- Vilkår
- Søkeresultater
- Sitemap
- Cookie Policy
- Registrer ny bruker
- Logg inn